Key facts
- Tomorrow.Bio’s last known valuation is $28.2M (May 2025).
- It has raised $8.2M; the latest was Seed Round ($5.6M) in May 2025.
- Notable investors include Zain S Hasan Charitable Remainder Trust, Blast.Club, TruVenturo, Asia Venture Group, TEC Ventures (Germany) — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Tomorrow.Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Tomorrow.Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tomorrow.Bio
Provider of a cryopreservation service intended for long-term biological storage. The company utilizes advanced cooling techniques and specialized preservation methods to maintain individuals at low temperatures, ensuring cellular integrity while preventing ice crystal formation, enabling individuals who are seeking future medical advancements to potentially benefit from emerging technologies that may allow revival and treatment beyond current medical limitations.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2020
- Employees
- 20
- Website
- tomorrow.bio/
- Ownership
- Privately Held (backing)
Tomorrow.Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tomorrow.Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tomorrow.Bio in its N-PORT filings yet. We sweep new filings monthly.